ScholarLens Back to search
1997•European Journal of CancerRequires access

Cisplatin, etoposide and bleomycin infusion (PEBI regimen) in good-risk patients with germ cell tumors

Marco Colleoni, Rossella Graffeo, Giovanni Martinelli, Michele Ghielmini, Giovanni Marini, F Cavalli, Aron Goldhirsch

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Etoposide, Bleomycin, Germ cell tumors, Cisplatin, Medicine, Regimen, Oncology, Chemotherapy

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Cisplatin, etoposide and bleomycin infusion (PEBI regimen) in good-risk patients with germ cell tumors — Research Paper | ScholarLens